Precision Genomics Collaboratory News

The Sequencing and Genomic Technologies (SGT) core facility has added two new sequencers to the lab: the PacBio Revio long-read sequencer and the Illumina NovaSeq X Plus short-read sequencer.

Duke Health has begun major research to find out why some people stay healthy while others develop diseases. The 6-year study will gather DNA data from 150,000 Duke patients.

A Duke Health transplant patient decided to give back by joining OneDukeGen, the new precision medicine study that will analyze the DNA of 150,000 Duke patients and research study participants.

In a new study published in The Journal of Clinical Investigation, researchers performed metabolomic profiling on three different cohorts of patient samples to see which metabolites might predict long-term major adverse cardiovascular events (MACE) among patients with diabetes.

CTSI has launched the Center for Precision Health (CPH), a collaboration led by Svati Shah that will harness the power of genomic, biomarker, and health data to transform patient care and population health.

Researchers have developed a blood test that detects Parkinson’s disease, potentially establishing a way to help diagnose the condition before nervous system damage worsens.

Andrew Landstrom, MD, PhD, associate professor of pediatrics, is hoping to change that. He helped lead efforts with the American Heart Association (AHA) to develop an educational curriculum that addresses the educational needs of health care providers, including clinicians, researchers, and medical students within the cardiovascular field.

The Sequencing and Genomic Technologies Core Facility will host a launch party for the new PacBio Revio long-read sequencer.  Agenda:

The Duke University Health System and School of Medicine are launching OneDukeGen, a precision medicine study that will advance healthcare through cutting-edge research and collaboration.

The Duke University School of Medicine Office of Biomedical and Graduate Education (OBGE) and Precision Genomics Collaboratory awarded 12 pilot grants of $2,000 each to SOM Biomedical PhD students. The goal of these grants is to support our students in scientific and educational efforts to bolster their graduate training experiences. These awards will help further research in a broad array of topics including into diseases like osteoarthritis, cancer, end-stage renal disease, genetic cardiomyopathies and more.